Page 1163 - Clinical Immunology_ Principles and Practice ( PDFDrive )

1128 Part NINE Transplantation

25. Gennery AR, Khawaja K, Veys P, et al. Treatment of CD40 ligand 38. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic
deficiency by hematopoietic stem cell transplantation: a survey of the granulomatous disease with myeloablative conditioning and an
European experience, 1993–2002. Blood 2004;103:1152–7. unmodified allograft: a survey of the European experience, 1985–2000.
26. Permaul P, Narla A, Hornick JL, et al. Allogeneic hematopoietic stem cell Blood 2002;100:4344–50.
transplantation for X-linked ectodermal dysplasia and immunodeficiency: 39. Güngör T, Teira P, Slatter M, et al. Reduced-intensity conditioning and
case report and review of outcomes. Immunol Res 2009;44:89–98. HLA-matched haemopoietic stem-cell transplantation in patients with
27. Pai SY, Levy O, Jabara HH, et al. Allogeneic transplantation successfully chronic granulomatous disease: a prospective multicentre study. Lancet
corrects immune defects, but not susceptibility to colitis, in a patient with 2014;383:436–48.
nuclear factor-κB essential modulator deficiency. J Allergy Clin Immunol 40. Qasim W, Cavazzana-Calvo M, Davies EG, et al. Allogeneic hematopoietic
2008;122:1113–18. stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics
28. Fish JD, Duerst RE, Gelfand EW, et al. Challenges in the use of allogeneic 2009;123:836–40. Erratum in: Pediatrics 2009;123:1436.
hematopoietic SCT for ectodermal dysplasia with immune deficiency. 40a. Moutsopoulos NM, Zerbe CS, Wild T, et al. Interleukin-12 and
Bone Marrow Transplant 2009;43:217–21. interleukin-23 blockade in leukocyte adhesion deficiency type 1. N Engl J
29. Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and Med 2017;376:1141–6.
lineage-specific chimerism in 194 Wiskott–Aldrich Syndrome patients 41. Fioredda F, Iacobelli S, van Biezen A, et al. Stem cell transplantation in
treated by hematopoietic cell transplantation between 1980–2009: an severe congenital neutropenia: an analysis from the European Society for
international collaborative study. Blood 2011;118:1675–84. Blood and Marrow Transplantation. Blood 2015;126:1885–92.
30. Stepensky P, Krauss A, Goldstein G, et al. Impact of conditioning on 42. Rao A, Kamani N, Filipovich A, et al. Successful bone marrow
outcome of hematopoietic stem cell transplantation for Wiskott-Aldrich transplantation for IPEX syndrome after reduced-intensity conditioning.
syndrome. J Pediatr Hematol Oncol 2013;35:e234–8. Blood 2007;109:383–5.
31. Marsh RA, Jordan MB, Filipovich AH. Reduced-intensity conditioning 43. Horino S, Sasahara Y, Sato M, et al. Selective expansion of donor-derived
haematopoietic cell transplantation for haemophagocytic regulatory T cells after allogeneic bone marrow transplantation in a
lymphohistiocytosis: an important step forward. Br J Haematol patient with IPEX syndrome. Pediatr Transplant 2014;18:E25–30.
2011;154:556–63. 44. Kucuk ZY, Bleesing JJ, Marsh R, et al. A challenging undertaking: Stem
32. Booth C, Gilmour KC, Veys P, et al. X-linked lymphoproliferative disease cell transplantation for immune dysregulation, polyendocrinopathy,
due to SAP/SH2D1A deficiency: a multicenter study on the enteropathy, X-linked (IPEX) syndrome. J Allergy Clin Immunol
manifestations, management and outcome of the disease. Blood 2016;137:953–955.e4.
2011;117:53–62. 45. Al-Herz W, Chu JI, van der Spek J, et al. Hematopoietic stem cell
33. Marsh RA, Bleesing JJ, Chandrakasan S, et al. Reduced-intensity transplantation outcomes for 11 patients with dedicator of cytokinesis 8
conditioning hematopoietic cell transplantation is an effective treatment deficiency. J Allergy Clin Immunol 2016;138:852–9.
for patients with SLAM-associated protein deficiency/X-linked 46. Dobbs K, Domínguez Conde C, Zhang SY, et al. Inherited DOCK2
lymphoproliferative disease type 1. Biol Blood Marrow Transplant Deficiency in Patients with Early-Onset Invasive Infections. N Engl J Med
2014;20:1641–5. 2015;372:2409–22.
34. Marsh RA, Rao K, Satwani P, et al. Allogeneic hematopoietic cell 47. Krenger W, Blazar BR, Holländer GA. Thymic T-cell development in
transplantation for XIAP deficiency: an international survey reveals poor allogeneic stem cell transplantation. Blood 2011;117:6768–76.
outcomes. Blood 2013;121:877–83. 48. Czechowicz A, Kraft D, Weissman IL, et al. Efficient transplantation via
35. Eapen M, DeLaat CA, Baker KS, et al. Hematopoietic cell transplantation antibody-based clearance of hematopoietic stem cell niches. Science
for Chediak-Higashi syndrome. Bone Marrow Transplant 2007;39: 2007;318:1296–9.
411–15. 49. Liu A, Vosshenrich CA, Lagresle-Peyrou C, et al. Competition within the
36. Pachlopnik Schmid J, Moshous D, Boddaert N, et al. Hematopoietic stem early B cell compartment conditions B cell reconstitution after
cell transplantation in Griscelli syndrome type 2: a single-center report hematopoietic stem cell transplantation in non-irradiated recipients.
on 10 patients. Blood 2009;114:211–18. Blood 2006;108:1123–8.
37. Kuhns DB, Alvord WG, Heller T, et al. Residual NADPH oxidase and 50. Wils EJ, Cornelissen JJ. Thymopoiesis following allogenic stem cell
survival in chronic granulomatous disease. N Engl J Med transplantation: new possibilities for improvement. Blood Rev
2010;363:2600–1. 2005;19:89–98.